Debevoise & Plimpton LLP has advised Artificial Labs (“Artificial”) in its £8 million Series A+ funding round.
The investment was led by the publicly listed fintech fund, Augmentum Fintech, with participation from existing investors including MS&AD Ventures and FOMCAP IV.
Artificial is an insurtech company which uses cloud-based tools and machine learning techniques to give commercial insurers and brokers power over their data.
For full details, see the official release here.
The Debevoise team advising Artificial was led by international consultant Clare Swirski, assisted by associate Mark Hume.